The role of zidovudine in development of lipoatrophy.
Moyle
Graeme J
GJ
Chelsea & Westminster Hospital, London, UK.
D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects; D000818:Animals; D019380:Anti-HIV Agents / Q000009:adverse effects*; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced*; D006801:Humans; D051379:Mice; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D015215:Zidovudine / Q000009:adverse effects*
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine